Login / Signup

Decision Making in Proliferative Diabetic Retinopathy Treatment.

Mary B KansoraRaquel Goldhardt
Published in: Current ophthalmology reports (2019)
Management of PDR requires the identification of high risk characteristics for PDR and the decision regarding the most appropriate treatment modality. The risk to benefit ratio for each treatment modality must be considered in determining the appropriate choice between surgical intervention (PRP) versus medical intervention with anti-VEGF.
Keyphrases
  • diabetic retinopathy
  • healthcare
  • replacement therapy
  • vascular endothelial growth factor